{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:08:16Z","timestamp":1792714096500,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":74,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811057649","type":"print"},{"value":"9789811057656","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-5765-6_2","type":"book-chapter","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T05:09:35Z","timestamp":1508389775000},"page":"11-21","source":"Crossref","is-referenced-by-count":137,"title":["Hepatitis B Virus-Associated Hepatocellular Carcinoma"],"prefix":"10.1007","author":[{"given":"Youhua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"2_CR1","unstructured":"Globocan (2012) Estimated cancer incidence, mortality and prevalence worldwide in 2012. International agency for research on cancer, World Health Organization, http:\/\/globocan.iarc.fr"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM (2004) Hepatitis B virus infection\u00a0\u2013 natural history and clinical consequences. N Engl J Med 350:1118\u20131129","journal-title":"N Engl J Med"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030\u20133044","journal-title":"Int J Cancer"},{"issue":"Suppl","key":"2_CR4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","volume":"47","author":"S Mittal","year":"2013","unstructured":"Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47(Suppl):S2\u2013S6","journal-title":"J Clin Gastroenterol"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0030-1247128","volume":"30","author":"M Sherman","year":"2010","unstructured":"Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30:3\u201316","journal-title":"Semin Liver Dis"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.2910630405","volume":"63","author":"JM Yuan","year":"1995","unstructured":"Yuan JM, Ross RK, Stanczyk FZ, Govindarajan S, Gao YT, Henderson BE, Yu MC (1995) A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer 63:491\u2013493","journal-title":"Int J Cancer"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","volume":"9","author":"JD Yang","year":"2011","unstructured":"Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR (2011) Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 9:64\u201370","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","volume":"126","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460\u2013468","journal-title":"Gastroenterology"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","volume":"350","author":"B Bressac","year":"1991","unstructured":"Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429\u2013431","journal-title":"Nature"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","volume":"42","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218\u2013224","journal-title":"J Hepatol"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","volume":"47","author":"N Brau","year":"2007","unstructured":"Brau N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ, North American Liver Cancer in HIVSG (2007) Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 47:527\u2013537","journal-title":"J Hepatol"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","volume":"32","author":"P Farci","year":"2012","unstructured":"Farci P, Niro GA (2012) Clinical features of hepatitis D. Semin Liver Dis 32:228\u2013236","journal-title":"Semin Liver Dis"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.23163","volume":"50","author":"SH Wang","year":"2009","unstructured":"Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ (2009) Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50:1392\u20131402","journal-title":"Hepatology"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121\u2013124","journal-title":"Science"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2011.12.045","volume":"142","author":"SH Wang","year":"2012","unstructured":"Wang SH, Yeh SH, Lin WH, Yeh KH, Yuan Q, Xia NS, Chen DS, Chen PJ (2012) Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha. Gastroenterology 142:989\u2013998. e984","journal-title":"Gastroenterology"},{"key":"2_CR16","first-page":"3","volume":"3","author":"GS Qian","year":"1994","unstructured":"Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People\u2019s Republic of China. Cancer Epidemiol Biomark Prev 3:3\u201310","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, Taiwan Community-Based Cancer Screening Project G (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168\u2013174","journal-title":"N Engl J Med"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","volume":"47","author":"HC Sun","year":"2007","unstructured":"Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47:684\u2013690","journal-title":"J Hepatol"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, Group R-HS (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65\u201373","journal-title":"JAMA"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Yang HI, Iloeje UH, Group R-HS (2009) Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49:S72\u2013S84","journal-title":"Hepatology"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.2007.13.2043","volume":"26","author":"HL Chan","year":"2008","unstructured":"Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, Lam Chan S, Yeo W, Sung JJ, Mok TS (2008) High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 26:177\u2013182","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"2_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin CL, Kao JH (2011) The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 26(Suppl 1):123\u2013130","journal-title":"J Gastroenterol Hepatol"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","volume":"118","author":"JH Kao","year":"2000","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554\u2013559","journal-title":"Gastroenterology"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","volume":"53","author":"HL Chan","year":"2004","unstructured":"Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ (2004) Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494\u20131498","journal-title":"Gut"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2004.09.048","volume":"127","author":"YH Ni","year":"2004","unstructured":"Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS, Chen DS (2004) Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 127:1733\u20131738","journal-title":"Gastroenterology"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1053\/gast.2002.37041","volume":"123","author":"JM Sanchez-Tapias","year":"2002","unstructured":"Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J (2002) Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123:1848\u20131856","journal-title":"Gastroenterology"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.2000.0321","volume":"10","author":"C Brechot","year":"2000","unstructured":"Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P (2000) Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 10:211\u2013231","journal-title":"Semin Cancer Biol"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1038\/sj.onc.1208628","volume":"24","author":"M Minami","year":"2005","unstructured":"Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y, Okanoue T (2005) Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene 24:4340\u20134348","journal-title":"Oncogene"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/gut.2004.054452","volume":"54","author":"Y Murakami","year":"2005","unstructured":"Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot P (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54:1162\u20131168","journal-title":"Gut"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"WK Sung","year":"2012","unstructured":"Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, Wang G, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, Zhou W, Zhang C, Hardwick J, Buser C, Xu J, Kan Z, Dai H, Mao M, Reinhard C, Wang J, Luk JM (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44:765\u2013769","journal-title":"Nat Genet"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.pgen.1003065","volume":"8","author":"D Ding","year":"2012","unstructured":"Ding D, Lou X, Hua D, Yu W, Li L, Wang J, Gao F, Zhao N, Ren G, Li L, Lin B (2012) Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet 8:e1003065","journal-title":"PLoS Genet"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","volume":"22","author":"MJ Ferber","year":"2003","unstructured":"Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, Nagorney DM, Gostout BS, Burgart LJ, Boix L, Bruix J, McMahon BJ, Cheung TH, Chung TK, Wong YF, Smith DI, Roberts LR (2003) Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 22:3813\u20133820","journal-title":"Oncogene"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","volume":"64","author":"HW Liang","year":"2016","unstructured":"Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K (2016) Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 64:278\u2013291","journal-title":"J Hepatol"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","volume":"25","author":"CC Lau","year":"2014","unstructured":"Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF, Wong N (2014) Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 25:335\u2013349","journal-title":"Cancer Cell"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/hep.510290336","volume":"29","author":"M Baptista","year":"1999","unstructured":"Baptista M, Kramvis A, Kew MC (1999) High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29:946\u2013953","journal-title":"Hepatology"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.0308232100","volume":"101","author":"SY Kuang","year":"2004","unstructured":"Kuang SY, Jackson PE, Wang JB, Lu PX, Munoz A, Qian GS, Kensler TW, Groopman JD (2004) Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A 101:3575\u20133580","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","volume":"100","author":"HI Yang","year":"2008","unstructured":"Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ, Group R-HS (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100:1134\u20131143","journal-title":"J Natl Cancer Inst"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/djp180","volume":"101","author":"S Liu","year":"2009","unstructured":"Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G (2009) Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101:1066\u20131082","journal-title":"J Natl Cancer Inst"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G (2014) Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications. J Hepatol 61:408\u2013417","journal-title":"J Hepatol"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2006.01.011","volume":"130","author":"BF Chen","year":"2006","unstructured":"Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153\u20131168","journal-title":"Gastroenterology"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","volume":"25","author":"YH Hsieh","year":"2004","unstructured":"Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023\u20132032","journal-title":"Carcinogenesis"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","volume":"97","author":"HC Wang","year":"2006","unstructured":"Wang HC, Huang W, Lai MD, Su IJ (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683\u2013688","journal-title":"Cancer Sci"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","volume":"55","author":"J Lucifora","year":"2011","unstructured":"Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, Zoulim F, Hantz O, Protzer U (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55:996\u20131003","journal-title":"J Hepatol"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/MCB.23.15.5282-5292.2003","volume":"23","author":"M Forgues","year":"2003","unstructured":"Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K, Feden J, Valerie K, Fukasawa K, Wang XW (2003) Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 23:5282\u20135292","journal-title":"Mol Cell Biol"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1074\/jbc.M708419200","volume":"283","author":"Y Wen","year":"2008","unstructured":"Wen Y, Golubkov VS, Strongin AY, Jiang W, Reed JC (2008) Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 283:2793\u20132803","journal-title":"J Biol Chem"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/hep.22542","volume":"48","author":"S Martin-Lluesma","year":"2008","unstructured":"Martin-Lluesma S, Schaeffer C, Robert EI, van Breugel PC, Leupin O, Hantz O, Strubin M (2008) Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48:1467\u20131476","journal-title":"Hepatology"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/sj.onc.1210998","volume":"27","author":"S Kim","year":"2008","unstructured":"Kim S, Park SY, Yong H, Famulski JK, Chae S, Lee JH, Kang CM, Saya H, Chan GK, Cho H (2008) HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 27:3457\u20133464","journal-title":"Oncogene"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.4161\/cc.10.20.17856","volume":"10","author":"S Knoll","year":"2011","unstructured":"Knoll S, Furst K, Thomas S, Villanueva Baselga S, Stoll A, Schaefer S, Putzer BM (2011) Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC. Cell Cycle 10:3554\u20133565","journal-title":"Cell Cycle"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1099\/0022-1317-83-11-2765","volume":"83","author":"JY Ahn","year":"2002","unstructured":"Ahn JY, Jung EY, Kwun HJ, Lee CW, Sung YC, Jang KL (2002) Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J Gen Virol 83:2765\u20132772","journal-title":"J Gen Virol"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11262-009-0441-3","volume":"40","author":"H Liu","year":"2010","unstructured":"Liu H, Shi W, Luan F, Xu S, Yang F, Sun W, Liu J, Ma C (2010) Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase. Virus Genes 40:174\u2013182","journal-title":"Virus Genes"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0168-8278(03)00215-0","volume":"39","author":"H Kojima","year":"2003","unstructured":"Kojima H, Kaita KD, Xu Z, Ou JH, Gong Y, Zhang M, Minuk GY (2003) The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice. J Hepatol 39:262\u2013268","journal-title":"J Hepatol"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M606774200","volume":"282","author":"D Cougot","year":"2007","unstructured":"Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Levy L, Buendia MA, Neuveut C (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282:4277\u20134287","journal-title":"J Biol Chem"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"ra1","DOI":"10.1126\/scisignal.2001906","volume":"5","author":"D Cougot","year":"2012","unstructured":"Cougot D, Allemand E, Riviere L, Benhenda S, Duroure K, Levillayer F, Muchardt C, Buendia MA, Neuveut C (2012) Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription. Sci Signal 5:ra1","journal-title":"Sci Signal"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1099\/vir.0.029512-0","volume":"92","author":"SH Park","year":"2011","unstructured":"Park SH, Jung JK, Lim JS, Tiwari I, Jang KL (2011) Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J Gen Virol 92:1309\u20131317","journal-title":"J Gen Virol"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1096\/fj.04-2126com","volume":"18","author":"TW Chung","year":"2004","unstructured":"Chung TW, Lee YC, Kim CH (2004) Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K\/AKT pathways: involvement of invasive potential. FASEB J 18:1123\u20131125","journal-title":"FASEB J"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2004.11.031","volume":"42","author":"FL Yu","year":"2005","unstructured":"Yu FL, Liu HJ, Lee JW, Liao MH, Shih WL (2005) Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. J Hepatol 42:520\u2013527","journal-title":"J Hepatol"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/onc.2011.255","volume":"31","author":"A Arzumanyan","year":"2012","unstructured":"Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, Feitelson MA (2012) Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 31:563\u2013572","journal-title":"Oncogene"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1099\/vir.0.83214-0","volume":"88","author":"J Pan","year":"2007","unstructured":"Pan J, Lian Z, Wallett S, Feitelson MA (2007) The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin. J Gen Virol 88:3275\u20133285","journal-title":"J Gen Virol"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JVI.74.6.2840-2846.2000","volume":"74","author":"Z Rahmani","year":"2000","unstructured":"Rahmani Z, Huh KW, Lasher R, Siddiqui A (2000) Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 74:2840\u20132846","journal-title":"J Virol"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.06442-11","volume":"86","author":"B Yang","year":"2012","unstructured":"Yang B, Bouchard MJ (2012) The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol 86:313\u2013327","journal-title":"J Virol"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","volume":"71","author":"A Arzumanyan","year":"2011","unstructured":"Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA (2011) Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res 71:3701\u20133708","journal-title":"Cancer Res"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"39076","DOI":"10.1074\/jbc.M305101200","volume":"278","author":"YG Yoo","year":"2003","unstructured":"Yoo YG, Oh SH, Park ES, Cho H, Lee N, Park H, Kim DK, Yu DY, Seong JK, Lee MO (2003) Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 278:39076\u201339084","journal-title":"J Biol Chem"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2006.051246","volume":"169","author":"P Sanz-Cameno","year":"2006","unstructured":"Sanz-Cameno P, Martin-Vilchez S, Lara-Pezzi E, Borque MJ, Salmeron J, Munoz de Rueda P, Solis JA, Lopez-Cabrera M, Moreno-Otero R (2006) Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. Am J Pathol 169:1215\u20131222","journal-title":"Am J Pathol"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","volume":"59","author":"FV Chisari","year":"1989","unstructured":"Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145\u20131156","journal-title":"Cell"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.20615","volume":"41","author":"HC Wang","year":"2005","unstructured":"Wang HC, Chang WT, Chang WW, Wu HC, Huang W, Lei HY, Lai MD, Fausto N, Su IJ (2005) Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41:761\u2013770","journal-title":"Hepatology"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/carcin\/bgr296","volume":"33","author":"LH Wang","year":"2012","unstructured":"Wang LH, Huang W, Lai MD, Su IJ (2012) Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis 33:466\u2013472","journal-title":"Carcinogenesis"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/gut.2008.174029","volume":"58","author":"F Luan","year":"2009","unstructured":"Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L, Sun W, Ma C (2009) Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Gut 58:1528\u20131537","journal-title":"Gut"},{"key":"2_CR68","first-page":"1855","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Child Hepatoma Study Group New England J Med 336:1855\u20131859","journal-title":"Taiwan Child Hepatoma Study Group New England J Med"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00006454-199305000-00037","volume":"12","author":"DP Greenberg","year":"1993","unstructured":"Greenberg DP (1993) Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J 12:438\u2013445","journal-title":"Pediatr Infect Dis J"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","volume":"61","author":"AJ Greenup","year":"2014","unstructured":"Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, Holdaway S, Samarasinghe D, Jackson K, Locarnini SA, Levy MT (2014) Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol 61:502\u2013507","journal-title":"J Hepatol"},{"key":"2_CR71","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B (2016) Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 374:2324\u20132334","journal-title":"N Engl J Med"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study G (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521\u20131531","journal-title":"N Engl J Med"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","volume":"53","author":"GV Papatheodoridis","year":"2010","unstructured":"Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A (2010) Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 53:348\u2013356","journal-title":"J Hepatol"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62:956\u2013967","journal-title":"J Hepatol"}],"container-title":["Advances in Experimental Medicine and Biology","Infectious Agents Associated Cancers: Epidemiology and Molecular Biology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-5765-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T17:44:30Z","timestamp":1570211070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-5765-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811057649","9789811057656"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-5765-6_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}